These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1261943)

  • 21. [Efficacy of intrathecal baclofen in the treatment of spasticity in stroke].
    Lamotte D; Cantalloube S
    Ann Readapt Med Phys; 2007 Apr; 50(3):165-9. PubMed ID: 17145092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral baclofen in children with cerebral palsy: a double-blind cross-over pilot study.
    Scheinberg A; Hall K; Lam LT; O'Flaherty S
    J Paediatr Child Health; 2006 Nov; 42(11):715-20. PubMed ID: 17044900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intrathecal baclofen in the treatment of severe spastic tetraplegia and dystonia in children and adolescents].
    Illum NO; Hansen FJ; Fischer C; Uldall PV; Nielsen OA
    Ugeskr Laeger; 2003 Apr; 165(17):1755-9. PubMed ID: 12768902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and management of intrathecal baclofen pump complications: a comparison of pediatric and adult patients.
    Vender JR; Hester S; Waller JL; Rekito A; Lee MR
    J Neurosurg; 2006 Jan; 104(1 Suppl):9-15. PubMed ID: 16509474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral baclofen increases maximal voluntary neuromuscular activation of ankle plantar flexors in children with spasticity due to cerebral palsy.
    van Doornik J; Kukke S; McGill K; Rose J; Sherman-Levine S; Sanger TD
    J Child Neurol; 2008 Jun; 23(6):635-9. PubMed ID: 18281622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Satoyoshi's syndrome: a syndrome of progressive muscle spasm, alopecia, and diarrhea].
    Satoyoshi E
    Nihon Rinsho; 1990 Jul; 48(7):1540-6. PubMed ID: 2402072
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of beta-(p-clorophenil)-gamma-aminobutirric acid in the treatment of hemiplegic patients with hypertonius (author's transl)].
    Prati R; Soriani S
    Riv Patol Nerv Ment; 1974 Oct; 95(5):651-2. PubMed ID: 4470264
    [No Abstract]   [Full Text] [Related]  

  • 28. Intrathecal baclofen.
    Ochs GA
    Baillieres Clin Neurol; 1993 Apr; 2(1):73-86. PubMed ID: 8143075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Spasticity and its treatment].
    Larsen TA; Teräväinen H
    Duodecim; 1985; 101(12):1216-9. PubMed ID: 4017913
    [No Abstract]   [Full Text] [Related]  

  • 30. Hyperthermia associated with baclofen withdrawal and increased spasticity.
    Mandac BR; Hurvitz EA; Nelson VS
    Arch Phys Med Rehabil; 1993 Jan; 74(1):96-7. PubMed ID: 8420527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of pediatric spasticity.
    Melnick ME; Shellenberger MK
    Compr Ther; 1982 Oct; 8(10):20-6. PubMed ID: 7140200
    [No Abstract]   [Full Text] [Related]  

  • 32. Pathophysiology and treatment of spasticity.
    Gulati SK
    J Assoc Physicians India; 1993 Apr; 41(4):225-6. PubMed ID: 8270566
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical trial of Baclofen].
    Destee A
    LARC Med; 1981 Oct; 1(1):89-91. PubMed ID: 6761520
    [No Abstract]   [Full Text] [Related]  

  • 34. Baclofen in chronic schizophrenia.
    Bigelow LB
    Psychopharmacol Bull; 1977 Jan; 13(1):4-5. PubMed ID: 319473
    [No Abstract]   [Full Text] [Related]  

  • 35. [Myotonolytic effect of Lioresal-A].
    Lević Z; Nikolić M
    Srp Arh Celok Lek; 1976 May; 104(5):341-5. PubMed ID: 1019743
    [No Abstract]   [Full Text] [Related]  

  • 36. [Research on the action of lioresal (Baclofen) and diazepam (Valium) in neurogenic spasmophilia (using an original method of polygraphic recording)].
    Popoviciu L; Făgărăsan M; Dulău E; Corfariu O; Trimbitas D; Badiu Gh; Iozonschi A; Jancsó I; Contiu T; Komjátszegi M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1976; 21(4):253-62. PubMed ID: 1088204
    [No Abstract]   [Full Text] [Related]  

  • 37. [Neuroleptic effect of baclofen in chronic schizophrenia (author's transl)].
    Kuhn R
    Arzneimittelforschung; 1976; 26(6):1187. PubMed ID: 989412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The assessment of drug treatment of spastic gait.
    Young RR
    J Neurol Neurosurg Psychiatry; 1982 Aug; 45(8):760-1. PubMed ID: 7131006
    [No Abstract]   [Full Text] [Related]  

  • 39. [Retabolil and nerobolil treatment of children with familial spastic paralysis].
    Zhovnir IK; Krotiuk LM
    Pediatr Akus Ginekol; 1975; (1):25. PubMed ID: 1228607
    [No Abstract]   [Full Text] [Related]  

  • 40. [Activation of spastic patients].
    Zuk T; Borten I
    Chir Narzadow Ruchu Ortop Pol; 1971; 36(1):107-12. PubMed ID: 5551604
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.